0022-1554/90/$3.30 Thejournal of Histochemistry
Copyright
© 1990
and Cytochemistry by The Histochemical Society,
Vol. 38, No. Inc.
MASASHI FUKAYAMA,’ NOBUAKI FLJNATA, YUKIKO MORIO KOIKE, JUN-ICHI WATANABE, and TETSURO ofPathology,
Received
of Tokyo
Tokyo
(JW);
for publication
Metropolitan
and
Third
March
23,
Komagome
Department 1989
Hospital
oflnternal
and
in revised
form
July
of brain-associated
(BASCA)
small-cell
in developing lung immunohistochemically with monodonal
and
bronchial tubes were diffusely positive at the pseudoglandular stage. Ciliated cells lost immunoreactivity shortly after their emergence, but non-ciliated cells, induding endocrine cells, lost it at the alveolar stage. The immunoreactivity in mesenchymal cells was reduced in the proximal airway,
Introduction Monoclonal antibodies (MAb) were raised noma of the lung (SCCL) for investigation
against small-cell of this particular
carcitype
oflung cancer (14). Interestingly, many of the MAb also react with normal and neoplastic neural tissues, and the majority of them (4,11,12,15) recognize a common antigen, brain-associated smallcell cancer man brain
antigen (BASCA), which was recently (16). BASCA is a 124 KD cell surface
containing several
three questions
no unequivocal
different about
epitopes the
evidence
in the lung
is tumor in some
sp&ific in the lung. non-SCCL (2,12,17),
neuroendocnine
tissue,
However,
significance
has
BASCA
(18).
been
the question but
differentiation
there
of BASCA
obtained
BASCA
purified antigen,
for
is whether expression
this
fact
in non-SCCL
have
As
presence
of
or not
been
been
in SCCL. the
could
has
from huprobably
BASCA
31,
1989;
but
to: Masashi
Fukayama,
interpreted
August
positivity
ofMedical Tokyo,
(70),
4,
1989
Sciences, Japan.
(9A1651).
remained
period.
All
to be too simplistic for understanding plastic lungs. Therefore, in an attempt first investigated BASCA vealed that the developing pression
undergoes
vation, sion
in its spatial
nificance
microscopy
of BASCA
be difficult
and
lung, which neand that this ex-
temporal
pattern.
this changing pattern with BASCA organs and in fibrotic or neoplastic were based solely on morphological
our immunohistochemical by electron
expression in neothis question, we
expression in developing lung expresses BASCA
changes
then tried to compare sion in other developing Although our findings
ofBASCA to clarify
study will provide
in normal
to obtain
with
and other
defining some
neoplastic
We expres-
lungs. obser-
cell type
expres-
insights
into
the sig-
lungs
which
would
approaches.
as
(2). This view appears
3-18-22
Institute
be observed
MD, Department
Hospital,
MAEDA,
in the distal lung later during the endocrine tumors ofthe lung, defmed by diffuse synaptophysin immunoreactivity, expreased BASCA, but some non-endoaine carcinomas which also laCked densely cored granules ultrastructurally, showed BASCA positivity. The temporal and spatial pattern of BASCA expression in the developing lung suggests that BASCA plays an active role inlung morphogenesis. BASCA may be expressed as an oncofetal substance in some non-endocrine carcinomas of the lung. (J Histochem Cytochem 38:51-57, 1990) KEY WORDS: Brain-associated small-cell lung cancer antigen; Smallcell carcinoma of the lung; Surface antigen; Lung development; Monoclonal antibody; Human; Immunoelectron microscopy.
Materials
of Pathol-
Honkomagome,
and
and
Methods
non-neoplastic
consisted
of fetal
lung lungs
and 28), days and 3 months), and tumors with or without adults, were sampled at 20,
Metropolitan Komagome Tokyo 113, Japan.
YOSHIHARU
of Tokyo
accepted
postnatal
try,
I Correspondence
HAYASHI,
(BASCA)
OKABE
University
Normal
ogy, Tokyo Bunkyo-ku,
Antigen
(MIN1YH,YM,MK);
Medicine,
lung cancer antiin lung tumors was investigated and immunoelectron miaoscopically antibodies recognizing different epitopes of BASCA. In fetal lung, epithelial and mesenchymal cells had different spatial and temporal expression ltterns, in contrast to the consistent ttem in neural cells The cell membranes ofepitheial cells ofthe proximal Expression
gen
1990
USA.
Article
Brain-associated Small-cell Lung Cancer Is Expressed in Developing Lung: An Immunohistochemical and Immunoelectron Microscopic Study
University
51-57,
Printedin
Original
Department
pp.
1,
21,
22,
23,
(n
tissues, =
studied
11; gestational
by immunohistochemisweeks
8,
14,
16,
17,
19,
and infant lungs (n - 3; ages 1 and 8 non-neoplastic portions oflungs resected for lung fibrosis (n = 2 of each). Lung tissues, except for autopsy. To clarify the significance of BASCA in newborn
51
Downloaded from jhc.sagepub.com at VIRGINIA COMMONWEALTH UNIV on March 15, 2015
52
FUKAYAMA,
fetal differentiation, fetal and adult kidneys (n = 9 and 2, respectively), fetal thymuses (n - 10), and fetal and adult brains (n =2 of each) were also examined for comparison. The neoplastic tissues studied were endocnine tumors Itwo carcinoid tumors, eight SCCL, and one atypical endocrine tumor (5,9)1, and non-endocrine carcinomas (24 squamous cell carcinomas, 29 adenocarcinomas, one adeno-squamous cell carcinoma, and five large-cell carcinomas). To define endocrine and non-endocrine tumors, the tumor tissues were screened using an MAb for synaptophysin, which is a constituent of synaptic vesicles. Diffuse staining for synaptophysin classifled the tumor as an endocrine tumor (8). Tissues were fixed overnight with periodate-lysine-panaformaldehyde (PlY), embedded in OCT compound, frozen in dry ice-hexane, and stored at - 80C until immunohistochemical and immunoelectron microscopic studies were performed. Sections were cut at 5 tm with a cryostat for immunohistochemistry. Immunohistochemistry. Immunohistochemistry was performed by the indirect enzyme method (10), using MAb directed to SCCL for all tissues. The MAb reactive with BASCA included TFS4 (11), TFS6(18), MOC1 (2,4) (Bio-Science Products; Emmenbrucke, Switzerland), and 6H7 (12) (provided by Dr. T Okuda, Biological Science Institute, Nippon Zeon, Kawasaki, Japan and Dr. T Kameya, Department of Pathology, Kitasato University, Sagamihara,Japan). These MAb recognize at least two and possibly three different epitopes (18). All four MAb react with purified BASCA, but TFS6, which was obtained using BASCA as immunogen, did not immunolabel the viable SCCL cells, suggesting that the epitope recognized by TFS6 is not present at the outer side of the membrane. In contrast, the other three MAb reacted with viable cells, but 6H7 showed no interaction with TFS4
Table
1 . BASCA
in fetal
adult
and
HAYASHI,
FUNATA,
MAEDA,
KOIXE,
WAIANABE,
OKABE
or MOC1 in competitive inhibition assay of BASCA. Therefore, BASCA has at least two (6H7 and TFS4/MOC1), and possibly a third (TFS6), epitopes. The MAb for synaptophysin (SY38)was purchased from Boehninger (Mannheim, FRG). The cryostat sections were immunostained with MAb in optimal dilution; 1 ng/ml for l’FS4, 10 ng/ml for TFS6, iSo for cornmercially available MOC1, 1 pg/mlfor6H7, and 3 tg/ml for synaptophysin. Immunoelectron Microscopy (IEM). The pre-embedding method for LEM was applied to representative cases: fetal lungs (n = 7), adult lungs with fibrosis (n = 2), SCCLS (n = 4), carcinoids (n = 2), atypical endocnine rumor (n = 1), squamous cell carcinomas (n - 4), and adenocarcinomas (n 1). Ten-micrometer sections adjacent to those for light microscopy were immunostained with MAb for BASCA as described above. The sections were reacted overnight with Fab fragments of rabbit anti-mouse immunoglobulin conjugated with horseradish percacidase. The sections were post-fixed with 1.0% glutaraldehyde in PBS for 15 mm, washed, and preincubated with 0.02% 3,3’-diaminobenzidine, 10 mM sodium azide, and 1% dimethylsulfoxide
in 0.05
M Tris buffer,
pH
7.6,
for 30 mm.
reaction was developed by adding 0.005% sections were post-fixed with 1.0% osmium tetroxide perature, dehydrated in ethanol, and embedded in sections were viewed with a Hitachi H-7000 electron tification of cell types in detail, adjacent ultra-thin stained with uranyl acetate and lead citrate.
Then
the
H2O2 for 5 mm. The for 1 hr at room ternEpon 812. Ultra-thin microscope. For ideasections were doubly
peroxidase
ControlStudies Controlstudies induded the replacement of MAb with non-immune mouse immunoglobulin and omission of the MAb, applied to all cases for light microscopy and to selected cases (frtal lungs, carcinoid tumors, and two non-SCCL) for electron microscopy.
lunga Epitheium/Non-n
eural
mesendsyme
Neural
Dismi lungb
tissue
e
btonchusb
Kidney
Thymus
Brain
Fiber
Fetus *8c (20)’
I
-
+
+
+
I
+
*14(75)
-/++
++I++
#{149}16(95)
-/++
++/+
+
nae
+
na
++/++
na
+
+
+
-I-
na
++
-I-
++
-/++
na(+)
++/++
-I-
-/++
±1±
++/++
-I-
20
-/++
na(±)
++/++
-I-
na na na na
21
/++
±1-
++I++
-I-
na
++
na(-)
++I++
-I-
na
++
17 #{149}19(120)
22
22(190) 23(155) *28
+
++ ++ ++
-/++
±1-
++/++
-I-
-I++
+1±
++/++
-I-
na
++
-/++
-I-
++I++
±1-
na
++
++
++
Postnatal ldf(42
gw)S
4 -
.
I Large
negative bronchi
+
na na na
+
-1+ -1+
nf4 of ++
-I-
-I-
-I-
na
+
+
+
+
±1staining;
±
,a
are defined
mediate sized bronchi, of epithelial cells of C Gestational I Crown-rump
I
-
8d(3lgw) 3m Adult Fibrosis(-) *Fibrosis(+)
few or several
by the presence
the staining intermediate
week. length
results
positive
cells;
of cartilage
in epithelial
+
except
,
many
cells were nearly
sized bronchi were presented
positive
cells but not diffusely
the case of 8th gestational parallel
with
those
week. of large
positive; DiStal
+
+
lung means
bronchi.
When
,
diffuse
staining
glandular,
large bronchus
in parenthesis.
(mm).
‘ na, tissues were not available. fDays or months after birth. g Gestational weeks of neonates. aS f tissues were not found.
Downloaded from jhc.sagepub.com at VIRGINIA COMMONWEALTH UNIV on March 15, 2015
in most
canalicular,
was
cells;
,
or alveolar not
available,
IEM
was
performed.
structure.
the staining
In
interresults
BASCA
IN DEVELOPING
53
LUNG
f
.‘
_...
T
‘
#{149}
.
.
,
.
#{149}1
.
‘‘4’
,rI..e
#{149}.
..
.,
s
.
,,
4\
V
:
‘).._
-
.;6,
i:...:
.
.,,.-p’
.
:
#{149} #{149}
,/
-
t
,;e*
%
.
.
-.
.
c
!4
I
;:
#{149},J r
.
F
y-
: .
.
i
:..
#{149}
,
-
,
.
. :-
.
:-
,..
..,
;
. -y
.,.
F’.
‘
,
‘,
.--
,
a’
SI.
.-
,‘.
y
_-k*____
;.
.
,,.
-
.
.
.:
-
.
4 #{149}.:‘:;,
_
‘
________
“..*
Figure 1. BASCA expression in developing lung. Three structures are positive: epithelial cells of the bronchial tubes, mesenchymal cells surrounding the airway, and nerve fibers. 6W, gestationalweek. (A) Pseudoglandular stage(GW8), TFS4. Epithelial cells ofthe proximal part show diffuse positivity at the cell membrane, butthe epithelial cells ofthe glandular portion lack immunoreactivity. Note that mesenchymal positivity is present in both parts (arrowheads indicate distal portions, where only mesenchymal cells were positive). (B) Pseudoglandular stage(GWI4), MOC1. Immunoreactive epithelial cells are slightly reduced in alarge bronchus. Arrow indicates focal aggregation ofpositive mesenchymal cells. (C)Canalicularstage(GW21), TFS4 with counterstaining. Arrows pointto afew positive epithelial cells. Neural tissues are positive (arrowheads indicate ganglions). (0-F) Distal lung atthe pseudoglandular stage (0, GW14, MOCI) canalicular stage (E, GW21, TFS4), and postnatal period (F, 8 days, TFS4). Mesenchymal cells surrounding distal structures show positivity which appears to become sparse as the alveoli develop. Original magnifications: A x 100; B, D-F x 125; C x 250. Bars - 100 tm.
Results In all tissues studied, although the intensity with
others.
four MAb showed similar reaction of reaction with TFS6 was weaker
patterns, than that
Nonneoplastic
Lung
The results of immunohistochemistry lungs are presented in lhble 1.
Downloaded from jhc.sagepub.com at VIRGINIA COMMONWEALTH UNIV on March 15, 2015
on the fetal
tissues
and
adult
54
FUKAYAMA,
HAYASHI,
FUNAIA,
Pmfile
Developmental Kidney,
MAEDA,
and to the
constant
its absence
in the
thymus,
BASCA
in two specific
sociated
with
ofBASCA
and Mature
fetal
structures
in the
brain
kidney
of BASCA showed
the
presence
(Figure
2). One
of these
formation,
epithelial glomeruli
i.e.
cells with
any positivity.
The
Immunoelectron Cells
other
positive
The youngest fetus Positive immuno-
tial
the airway,
two
and temporal changes At the pseudoglandular
8-17),
epitheial
changed in
lung
stage
and
nerve
fibers.
considerably
along
morphology of fetal
cells in the proximal
BASCA with
spa-
(3).
lung
pseudoglandulan
emerged, the
portion
ofthe
week
bronchial
tubes
showed (Figure
diffuse immunostaining with MAb on their cell membranes 1A). The proximal portion, i.e., future bronchi, was charac-
terized
by undulated
fibers
at the outer
seen in the as a glandular chymal tive.
sheath
epithelial structure
cells of the distal at this stage(Figures
cells surrounding They
surrounded
only the distal immunoreactivity portion
than
and bundles ofdensely positive of the tubes. No immunoreactivity
epitheia
tip
the bronchial both
in the proximal
was
portion, which appeared IA, lB. and 1D). Mesentubes
the proximal
lacked positive in mesenchymal
nerve
were also immunoreacand
distal
portions,
and
cells (Figures 1A and 1D). The cells was stronger in the distal
portion,
and
was reduced
with
focal
immunoreaction
for BASCA
membrane
of ciliated
(Figure
BASCA-expressing the developing Some positive
tive cells drastically decreased There were some foci ofseveral cartilage), small in the respiratory maimed
negative
bronchi, and bronchioles (Figure
showed strong positivity During the alveolar tive
cells
could
cells
in the
adult
lungs
bronchial tree (Figure cells in large bronchi
bronchioles. and the
1E). Mesenchymal
However, canalicular cells
1C). (with
epithelial structures in the distal
for BASCA
(Figure
disappeared
and
filaments, indicating 3F). Immunoreactivity cells at the apposing
Non-ciliated
septal
In the of Schwann
differentia-
cells appeared to stage (Figure 3G).
(Figure
3E) surrounded
especially its distal bronchi had bundles
that they were smooth muscle was observed similar to that membranes where mesenchymal
MAb
portion. of actin
cells (Figure in epithelial cells are in portion had to be fibro-
cells.
nerve
fibers,
BASCA
was expressed
at the
lung
(Figure
membranes
cells.
in Fibrosed
epithelial
cells
cells with prominent
definite
intimate contact. Immunoreactive cells in the distal no bundles of filamentous structures, and appeared blastic
but
lateral
stage, when the imat the points of mem-
cells without
cells
they
3A),
cells were endocrine basal cells with
mesenchymal
at the
when at the
3B).
pat-
cells
in bronchiolized
for BASCA.
Positivity
cells ne-
some non-ciliated and cells with dense-cored
lung
in both
samples
Lung of fibrosed was seen
non-endocrine granules did
of fibrosed
tissue
structures at the
showed lateral
4A),
some
positivity
with
membranes
cells (Figure 4B). not show BASCA
of
Endocrine expression
lung.
demarcating the unstained epithelia. stage and early postnatal period, no posi-
be identified
cells were positive at the diffusely in the alveolar
in the positive
of immunoreac-
3D),
3C),
apparent cells,
(Figure
bronchial structure, cells surrounding the
In one of two specimens
the number
non-ciliated (Figure
This
epithelial
soon
cells
contact.
tion. Among these non-ciliated cells, endocrine be the dominant cell type at the canaliculan
BASCA
completed,
-expressing
used. became
continued to express BASCA at the canalicular munoreactivity appeared to be discontinuous
chial
has been
Ciliated
immunoneactivity
and transient aggregations ofpositive cells. These aggregations appeared to be associated with bronchial cartilage (Figure 1B). At the canalicular stage (gestational week 19-23) when bronbranching
points
stage.
showed
tonofilaments
(gestational
unstained
ofcell-to-cell
along
brane contact. These dense-cored granules
former
comprised
of BASCA
did not differ among the four MAb In the fetal bronchi, cell differentiation
mesenchymal
cells surrounding
structure surrounded
at the cell membranes
surface
in the
nephrogenic and immature glomerulan tufts
Lung
staining for BASCA was first identified in this fetus. Three different components in the lung showed similarly positive immunoreactions with four MAb (Figure 1): epithelia ofthe developing bronchi, expression
of
was as-
positive cells were observed by for BASCA was always seen
late Profile ofBASCA in Lung. a gestational age of 8 weeks.
and
To define BASCA-expressing cells, electron microscopy. Immunoreactivity tern
Developmental in the series had
subcapsular
which
Microscopy
in Fetal
,
in renal tubules fully developed
the mesenchymal cells in the medulla, unetenic buds or urinary tubules.
Figure 2. Fetal kidney also exhibits BASCA (GW14, MOC1). Posftive reaction is seen in glomerulus-forming structures(nephrogenic mesenchyme, renaltubules, and Immature glomeruli; arrows) and in mesenchymal cells surrounding ureteric buds (asterIsks). Note the absence of the reaction in fully developed glomeruli near the axis. Original magnification x 63 Bar - 100 pam.
OKABE
in Brain,
presence
glomerular
did not show
WAIANABE,
Thymus
In contrast
mesenchyme glomeruli.
KOIKE,
in epithelia,
but
the
mesenchymal
bronchioles and the alveolar entrance, and septa (Figure iF). There were no positive except
for
nerve
fibers.
BASCA
in Lung
Consistent with previous diffuse staining reaction synaptophysin
Tumors studies, all ofthe endocrine tumors for BASCA at the cell membrane
in the cytoplasm.
Downloaded from jhc.sagepub.com at VIRGINIA COMMONWEALTH UNIV on March 15, 2015
However,
in non-endocrine
showed and for carci-
*
.
.
F
.--.
,
Figure a Immuncelectron microscopy for BASCA in developing lung. (A) At GW14, TFS4: cilia emerge at the surface of some epithelial cells of the bronchial tubes. Positivity is present at the lateral membranes and not at the luminal side. (B-D) At the GW16 TFS4, counterstained with uranyl acetate and lead citrate: immunoreactivity is lost in ciliated epithelial cells. At this time, differentiated cells other than ciliated cells were identified, endocrine cells (C) and basal cells (D) (arrows indicate bundles of intermediate filaments or tonofilaments). These non-ciliated cells were reactive. Note absence of positivity at abluminal membranes. (E, F) As in epithelial cells, mesenchymal positivity is observed along the points of cell contact between peribronchial cells without specialized structures (E, GW14, TFS4)and apparent smooth muscle cells(F, GW14, TFS4). Asterisk in E indicatesfetal epithelia. (G)At the canalicular stage(GW21, MOC1), positive epithehal cells are reduced and endocrine cells (asterisks) are the predominating cell type among positive cells. Arrows and arrowheads indicate discontinuous positivity of endocrine cells and non-endocrine cells, respectively. Original magnifications: A x 4000; B x 4200; C x 8500; D x 6000; E x 3500; F x 7200; G x 3400. Bars = 2 pam.
55
Downloaded from jhc.sagepub.com at VIRGINIA COMMONWEALTH UNIV on March 15, 2015
56
FUKAYAMA,
FUNATA,
HAYASHI,
munofluorescence
study
that BASCA probably cell surface (‘ff54 and the outside
MAEDA,
oflive
KOIKE,
small-cell
WATANABE,
lung
has three independent MOC1, and 6H7) and
(TFS6)(18).
BASCA
cancer
OKABE
cells revealed
epitopes, two on the one inaccessible from
is selectively
expressed
on cell mem-
branes of small-cell carcinoma of the lung (SCCL) in lung tumors and of human brain cells among normal tissues (17). However, its
.
C-#{149}
..
.
-
expression in the developing In the present study, using
lung has not yet been fully investigated. MAb recognizing three different epi-
topes
these
of BASCA,
in the same
:
we found
specific
is expressed
structures
in fetal
epitopes
ofthe
non-neural
simultaneously
fetal
tissues,
lung.
present
Therefore,
although
BASCA
some
difference
.
in BASCA
molecules
BASCA
in fetal
neural tissues. and temporal Figure 4. (A) Fibrosis in an adult lung; hematoxylin and eosin. (B) Immunoelectron microscopy in bronchiolized epithelia. sitivity is seen atthe apposing membranes between ciliated and non-ciliated cells; MOC1. Original magnifications: A x 25; B x 2700. Bars: A - 200 pam; B = 2 pam.
nomas,
one
of 24 squamous
munoneactive were negative. four
squamous
for BASCA Furthermore,
cell carcinomas.
tophysin
could
positive identified
cases. Ultrastructurally, in BASCA-expressing
in contrast
cell (Figure some
be identified
to their
relative
Only
of fibroblastic
was
a few positive
in serial sections
diffusely
ofone
frequency
imcells in
cells for synapofthese
no dense-cored granules cells offour carcinomas
types of lung carcinomas did for non-neoplastic mesenchymal Iksitivity was ultnastructunally membranes
carcinomas
5), although keratinizing positive cells were identified
in all endocrine
BASCAcould be examined,
tumors.
Other
not show BASCA expression, except cells in one of 29 adenocarcinomas. present at the contact points between or
myofibnoblastic
cells.
may
in neural
lung
BASCA pattern
cells.
between
be present
is present
in epithelial,
in the former of expression,
and
adult
tissues.
mesenchymal,
and
two tissues has a different spatial in contrast to its consistency
As for the spatial
thelial cells are immature BASCA in mesenchymal
fetal
pattern,
cells in the cells is strongly
BASCA-expressing proximal expressed
epi-
bronchi, whereas in the distal part
of the lung where epithelial cells lack immunoreactivity. This spatial pattern of BASCA expression in epithelial and mesenchymal cells appears to parallel that in the fetal kidney: epithelial cells in the immature glomeruli and mesenchymal cells surrounding unetenic buds. This parallelism suggests that BASCA plays a common role in lung and kidney morphogenesis. In this regard, it is interesting
that
a neural
demonstrated mesenchymal
cell
adhesion
molecule
in fetal epithelial immunoreactivity
(NCAM)
cells of glomeruli, present for BASCA
was
recently
although the is not observed
for NCAM (13). Furthermore, N-cadhenin cell adhesion molecules, which were identified in brain cells of mouse and chicken, are expressed in various tissues of chicken embryos, and this expression seems to be related to a variety ofmorphological velopment (6). BASCA may be also a kind
events during deof cell adhesion mole-
cule, and the ultrastructural finding that BASCA is present at the points of cell membrane contact may further support
Discussion Brain-associated KD, recognized bition
small-cell lung cancer antigen is a molecule by the munine MAb TFS4 (16). Competitive
assay of binding
to affinity-purified
BASCA
and
surface
of 124 inhiim-
assumption. In developing
mouse
of mesenchyme gin and perhaps mesenchyme
lung
appeared
to be two
domains
distinguished on the basis of their embryonic ontheir morphogenic properties (19). The tracheal is derived
bronchial
mesenchyme
cells.
latter
The
there
only this
from shares
promote
mesodermal
mesenchyme,
common
budding
epitopes
and
with
branching
whereas neural
crest
of the bronchial
and tracheal epithelia in vitro, whereas the former lack such capability. Although we do not know the origin of human pulmonary mesenchyme, BASCA expression in mesenchymal cells appears to be related
to branching
and BASCA
expression
ofbronchial
ponent in the pulmonary In fetal epithelial cells, but is retained servation may sion
(5,9).
have
been
but
regarded
not
exclusive,
differentiation
was
immunoreactivity
rare
synaptophysin
cell carcinomas
Downloaded from jhc.sagepub.com at VIRGINIA COMMONWEALTH UNIV on March 15, 2015
with
the fetal
a morphogenic is lost in ciliated
for endocrine
component
period, comcells
stage. This obBASCA exprestumors
and atypical endocrine cells in non-endocrine
as an endocrine
ing the mukidirectional ules in squamous
during
cells at the canalicular with the finding that
lung: carcinoid tumor, SCCL, Although BASCA-expressing
nomas Figure 5. Diffuse immunostaining in a squamous cell carcinoma; MOd with counterstaining. Keratinizing cells are negative. In the adjacent section there was no synaptophysin immunoreactivity. Original magnification x 165. Bar 100 pam.
specific,
represent
mesenchyme. BASCA expression
in endocrine be consistent
is relatively
ofthe
tubes
may therefore
tumors carci-
(2), reflect-
oflung carcinomas (1), there or no dense-cored granBASCA-positive cells. BASCA
BASCA
can
IN DEVELOPING
be expressed
57
LUNG
without
accompanying
endocrine
cell
Funata
differen-
tiation, as it occurs in the bronchial epithelia at the pseudoglandular stage. Therefore, BASCA expression in non-endocrine carcinoma of the lung may represent an oncofetal form of expression. It is interesting to note that BASCA expression was found in the non-ciliated
cells of bronchiolized
structures
BASCA-expressing
cells were non-ciliated,
lar to those
bronchi
in fetal
ofa fibrosed
non-endocrine
at the pseudoglandular
stage.
by MAb
against
cells process
SCCL
is a
genesis
of the lung.
has additional
that
plays
Therefore,
significance
an important
BASCA
in lung
tumors
Future
studies
expression.
the molecular tumonigenesis.
structure
of BASCA
K:yose
DrH.
Hapkano
(Department
ofPathology,
ChildrenHospital)forpermitting
photographs
were
prepared
usto by Ms
infantlungs.
10.
1. Baylin
11.
McDowell 1987, 2.
AF: The
spectrum
of human
Edinburgh,
lung
neoplasms.
A, Wagenaar 55, FCS: Immunocyto-
chemical epithelial, 1987
using
of lung
cancer
heterogeneity
and neuroendocnine
antigens.
antibodies to Cancer Res 47:3225,
and differentiation of airway epithelium in In McDowell EM, ed. Lung carcinomas. EdinChurchill-Livingstone, 1987, 1
L, Poppema 5, NulendJK, ter Haar A, Schwander F, Postmus PE, The TH: Neuroendocrine differentiation
Dc Leij human
lung
progress
on peroxidase-labeled 1975
tumors
antibody
Okabe T, Kaizu T, Fujisawa M, WatanabeJ, Kojima l#{224}kakuF: Monoclonal antibodies to surface antigens cinoma of the lung. Cancer Res 44:5273, 1984
of
method.
K, Yamashita
T,
of small cell car-
14.
Souhami RL, Beverley PCL, Bobrow cancer. First international workshop. Takahashi
T, Ueda
R, Song
X, Nishida
of
D, Heitz the neural
133:227,
1988
LG: Antigens of small-cell Lancet 2:325, 1987 K, Shinzano
PU: cell lung
M, Namikawa
R,
carcinoma
E, Fukayama
and
Kulchitski
M, Shiozawa
cells.
Cancer
Y, Nakatsugawa
E, Ebbens antigen on
Res 45:2192, A, Hayashi
1986
16. Watanabe J, Okabe T, Fujisawa M, Th.kaku F, Fukayama M: Isolation of small cell cancer-associated antigen from human brain. Cancer Res
Broers JLV, Rot MK, Oostendorp T, Huysmans Wiersma-van Tilburg AJM, Vooijs GP, Remaekers
5. Furukawa
Recent
endocrine
Roth J, Zuber C, Wagner P, Blaha I, Bitter-Suermann Presence of the long chain form of polysialic acid adhesion molecule in Wilms’ tumor. Am J Pathol
In
Churchill-Livingstone,
346
burgh,
PK:
1’S, Trump BF: Atypical Lab Med 105:20, 1981
Aniyoshi Y, Ota K, Kato K, Nagatsu T, Imaizumi M, Abe T, Takahashi P Two novel cell surface antigens on small cell lung carcinoma defined by mouse monodonal antibodies NE-25 and PE-35. Cancer Res 46:4770,
3. Cutz E: Cytomorphology developing human lung.
4.
EM, Wilson Arch Pathol
13.
in
The
Nakane
VE, Moll R, Wiedemann B, Franke WW: Synaptophysin the bronchopulmonary tract: neuroendocnine cells, neubodies, and neuroendocnine neoplasms. Differentiation
Okuda T, Kasai K, Kameya T, Saito 5, Takase N: Monoclonal antibody directed against neuroendocrine properties of both normal and malignant cells. Hybridoma 7:569, 1988
Y Shiozawa.
EM, ed. Lung carcinomas.
detection neuronal,
in press
12.
Cited SB, Gazder
(suppl),
lung.’ Electron of atypical en-
5, Fujisawa
Ann NY Acad Sci 254:203,
15.
Literature
Microsc
of the studies
1987
9. McDowell
Tokyo Metropolitan
examine
in
roepithelial
Acknowledgments We thank
Lee I, Gould expressed
role in morpho-
expression
as an oncofetal
are necessary to determine lung differentiation and
8.
the lung.
in spatial and temporal pattern in contrast to its consistency in neural tissues. BASCA may be not only a common molecule in SCCL and but also a molecule
endocrine tumor microscopic
H, Th.keichi M: Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes ofchicken embryos. Dev Biol 120:215, 1987
It is pos-
molecule expressed in fetal non-neural tissues as well as in adult neural tissues. However, BASCA expression in fetal lungs changes
brain
docnine
6. Hatta K, D.kagi
34:115,
recognized
of ‘atypical
and immunoelectron granules. J Clin Electron
7. Kawanami 0, Ferrans VJ, Crystal RG: Structure of alveolar epithelial cells in patients with fibrotic lung disorders. Lab Invest 46:39, 1982
cells, simi-
sible that BASCA may be re-expressed when the constituent change with bronchiolization, i.e. , during the remodeling of the fibrotic lung (7). In conclusion, BASCA
lung.
N: A case
microscopic
1985
Y,
47:960,
17.
1987
WatanabeJ,
Y: Monoclonal non-small-cell
Okabe T, Fujisawa M, likaku antibody that distinguishes
lung
cancer.
Cancer
F, Hirohashi small-celllung
Res 47:826,
5, Shimosato
cancer from
1987
18. WatanabeJ,
Fukayama M, Fujisawa M, Takaku F, Okabe T: Brain associated small-cell lung cancer antigen (BASCA) has at least three epitopes. Proceedings of the first international workshop on SCLC antigens. Lung Cancer (suppl)4:105, 1988
19. WestonjA:
The embryonic and possible contributions dar AF, eds. The endocrine Saunders, 1984, 79
Downloaded from jhc.sagepub.com at VIRGINIA COMMONWEALTH UNIV on March 15, 2015
neural crest. Migration and differentiation to the developing lung. In Becker KL, (halung in health and disease. Philadelphia,